Jmir iconJmirSep 15, 2026 ~1 min source read

Automated Renal Tumor Segmentation in Computed Tomography Images Using a Global Attention–Based DeepLabV3+ Model: Algorithm Development and Validation

The model was rigorously evaluated on a private clinical dataset (n=218) and the KiTS19 benchmark (n=210). on the kits19 dataset maintained robust dsc to facilitate clinical translation demonstration-only online platform was developed.

Share this story

Send the public story page.

Useful takeaways from this story.

The rising global incidence of renal tumors necessitates precise diagnostic interventions.

The model was rigorously evaluated on a private clinical dataset (n=218) and the KiTS19 benchmark (n=210).

on the kits19 dataset maintained robust dsc to facilitate clinical translation demonstration-only online platform was developed.

Building the complete brief

The page is ready to read now. The fuller skim-friendly version will appear here automatically.

The useful part

The rising global incidence of renal tumors necessitates precise diagnostic interventions. Accurate segmentation of computed tomography (CT) scans is essential for nephron-sparing surgery and radiotherapy. However, conventional manual delineation is labor-intensive and prone to significant interobserver variability due to tumor morphological heterogeneity.

How it works

  • This study aims to develop and validate GAM-DeepLabV3+, an automated framework designed to address boundary ambiguity and high false-positive rates in complex renal imaging scenarios.
  • The model was rigorously evaluated on a private clinical dataset (n=218) and the KiTS19 benchmark (n=210).
  • on the kits19 dataset maintained robust dsc to facilitate clinical translation demonstration-only online platform was developed.
  • conclusions: gam-deeplabv3 framework provides an accurate efficient fully automated solution for renal tumor segmentation.
  • by overcoming boundary ambiguity optimizing feature fusion this approach shows potential as decision-support aid pending f...

What to take from it

There is an urgent clinical demand for robust, automated segmentation solutions. We propose an optimized encoder-decoder architecture specifically tailored for renal mass detection. Results: GAM-DeepLabV3+ consistently outperformed state-of-the-art baselines.

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app